To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DCBLD2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
445 supporting clones for gene DCBLD2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA719907   .a 1 to 320 2 to 321   tiling clone, capped   320/323
(99 %)
5 diff
(98.5 %id)
BG722378 testis .a 106 to 558 1 to 455       455/484
(94 %)
17 diff
(96.5 %id)
DA543043   .a 112 to 365 2 to 255   capped   254/254
(100 %)
1 diff
(99.7 %id)
AW300360 Kidney .a 112 to 543 432 to 1       432/432
(100 %)
1 diff
(99.8 %id)
AB073146 lung .a 113 to 6205 1 to 6093 A22X tiling clone,   6093/6093
(100 %)
0 diff
(100 %id)
AK056350   .a 120 to 2139 1 to 2020   available from FLJ,   2020/2020
(100 %)
3 diff
(99.9 %id)
DA034245   .a 121 to 346 2 to 227   capped   226/226
(100 %)
2 diff
(99.2 %id)
CN404531 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 124 to 481 1 to 358       358/358
(100 %)
1 diff
(99.8 %id)
TI_157609093   .a 125 to 543 467 to 49       419/686
(61 %)
0 diff
(100 %id)
TI_157610082   .a 125 to 543 478 to 60       419/668
(62 %)
0 diff
(100 %id)
TI_158431071   .a 125 to 543 486 to 68       419/1077
(38 %)
0 diff
(100 %id)
TI_158431285   .a 125 to 543 486 to 68       419/941
(44 %)
0 diff
(100 %id)
AW611673 Kidney .a 147 to 543 397 to 1       397/397
(100 %)
3 diff
(99.3 %id)
AF387547   .a 465 to 3403 1 to 2939 exact     2939/2939
(100 %)
1 diff
(100.0 %id)
BF732384 fibrotheoma, ovary .a 536 to 1227 1 to 692     Submitted on the opposite strand 692/693
(99 %)
1 diff
(99.9 %id)
TI_157598349   .a 536 to 1289 50 to 799     Submitted on the opposite strand 750/1025
(73 %)
9 diff
(99.2 %id)
TI_158433425   .a 536 to 1281 43 to 798     Submitted on the opposite strand 756/990
(76 %)
31 diff
(96.9 %id)
AW138866   .a 537 to 1141 1 to 605     Submitted on the opposite strand 605/605
(100 %)
0 diff
(100 %id)
BF732861 fibrotheoma, ovary .a 539 to 1227 1 to 691     Submitted on the opposite strand 691/692
(99 %)
12 diff
(98.3 %id)
AW070902 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .a 544 to 1238 1 to 696     Submitted on the opposite strand 696/703
(99 %)
16 diff
(97.8 %id)
BF434973 fibrotheoma, ovary .a 545 to 1110 1 to 566     Submitted on the opposite strand 566/566
(100 %)
1 diff
(99.9 %id)
AI420312 Prostate .a 554 to 1079 1 to 526     Submitted on the opposite strand 526/526
(100 %)
3 diff
(99.5 %id)
AI565996 Kidney .a 554 to 1057 1 to 504     Submitted on the opposite strand 504/504
(100 %)
0 diff
(100 %id)
BM905706 leiomyosarcoma, uterus .a 574 to 1347 1 to 774       774/1061
(72 %)
9 diff
(99.2 %id)
DA649030   .a 597 to 1177 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA077583 cerebellum .a 599 to 1171 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BG178371 adenocarcinoma, cell line, Prostate .a 609 to 1304 16 to 721       706/908
(77 %)
26 diff
(97.2 %id)
TI_1948141752   .a 613 to 1304 131 to 822       692/1344
(51 %)
24 diff
(98.3 %id)
TI_1948141753   .a 613 to 1351 122 to 862       739/1226
(60 %)
16 diff
(98.7 %id)
TI_1948142075   .a 613 to 1430 122 to 936       815/1306
(62 %)
29 diff
(97.8 %id)
TI_1948142076   .a 613 to 1563 125 to 1072       948/1247
(76 %)
22 diff
(98.3 %id)
TI_1948142416   .a 613 to 1306 126 to 818       693/1374
(50 %)
11 diff
(99.2 %id)
TI_1948142417   .a 613 to 1559 125 to 1076   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 952/1268
(75 %)
18 diff
(98.6 %id)
TI_1948142751   .a 613 to 1351 129 to 870       740/1375
(53 %)
23 diff
(98.4 %id)
TI_1948142752   .a 613 to 1686 120 to 1191       1073/1230
(87 %)
48 diff
(96.1 %id)
CV029415 mixed .a 614 to 1244 1 to 631       631/631
(100 %)
4 diff
(99.4 %id)
AA885289 pooled .a 626 to 1084 1 to 459     Submitted on the opposite strand 459/459
(100 %)
0 diff
(100 %id)
AK302649 testis .a 633 to 2858 1 to 2226       2226/2226
(100 %)
2 diff
(100.0 %id)
DB075087 testis .a 634 to 1176 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DB454950 testis .a 639 to 1126 1 to 488       488/488
(100 %)
2 diff
(99.6 %id)
BP280887   .a 644 to 1226 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP279679   .a 660 to 1240 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
D29810   .a 681 to 2051 1 to 1384       1350/1388
(97 %)
34 diff
(97.6 %id)
N31244 melanocyte .a 690 to 1101 1 to 412       412/421
(97 %)
8 diff
(98.1 %id)
AA147128 colon, tumor .a 726 to 1210 1 to 483   fully sequenced,   483/483
(100 %)
4 diff
(99.2 %id)
BX470932   .a 794 to 1434 1 to 641       641/641
(100 %)
4 diff
(99.4 %id)
BP268462 thyroid .a 827 to 1409 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP268878 thyroid .a 827 to 1405 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BX475057   .a 844 to 1416 1 to 573       573/573
(100 %)
2 diff
(99.7 %id)
AI750960 Bone, Hip .a 868 to 1325 9 to 466       458/466
(98 %)
0 diff
(100 %id)
CN404527 embryonic stem cells, DMSO-treated H9 cellline .a 930 to 1552 649 to 27     Submitted on the opposite strand 623/649
(95 %)
2 diff
(99.7 %id)
AW383889 head_neck .a 940 to 1550 46 to 656       611/664
(92 %)
20 diff
(97.0 %id)
BF350722 head_neck .a 941 to 1239 1 to 299       299/299
(100 %)
6 diff
(98.0 %id)
AW383890 head_neck .a 947 to 1469 66 to 587       522/587
(88 %)
7 diff
(98.9 %id)
CN485165 eye .a 953 to 1552 624 to 25     Submitted on the opposite strand 600/624
(96 %)
3 diff
(99.6 %id)
BP236517 coronary artery .a 957 to 1539 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
CF130168 Chondrosarcoma Lung Metastasis cell lines, lung .a 973 to 1559 1 to 585   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 585/593
(98 %)
5 diff
(99.2 %id)
TI_154192105   .a 973 to 1559 51 to 635   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 585/1005
(58 %)
5 diff
(99.6 %id)
N46066 melanocyte .a 986 to 1441 1 to 457       457/459
(99 %)
4 diff
(99.2 %id)
BF764869 colon_est .a 991 to 1245 259 to 4     Submitted on the opposite strand 256/259
(98 %)
7 diff
(97.3 %id)
DA706004   .a 998 to 1563 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA706050   .a 998 to 1557 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
H84766 eye, retina .a 1012 to 1333 324 to 1     Submitted on the opposite strand 324/324
(100 %)
4 diff
(98.8 %id)
AA147037 colon, tumor .a 1180 to 1786 603 to 1   fully sequenced,   603/603
(100 %)
10 diff
(98.4 %id)
N21309 melanocyte .a 1604 to 2138 538 to 1       538/538
(100 %)
5 diff
(99.1 %id)
BE738215 brain, glioblastoma .a 5395 to 6152 775 to 2       774/891
(86 %)
0 diff
(100 %id)
BE879701 large cell carcinoma, undifferentiated, lung .a 5397 to 6126 1 to 722       722/926
(77 %)
24 diff
(97.5 %id)
TI_154057723   .a 5434 to 6204 866 to 96   AAA   771/929
(82 %)
17 diff
(98.2 %id)
TI_159687441   .a 5442 to 6197 884 to 138   AAA   747/934
(79 %)
50 diff
(94.7 %id)
N41448 melanocyte .a 5447 to 5864 1 to 420   fully sequenced,   420/420
(100 %)
5 diff
(98.9 %id)
BQ774055 Bone, Human Chondrosarcoma Cell Line .a 5471 to 6204 748 to 17   AAA   732/733
(99 %)
3 diff
(99.6 %id)
BU628593 Bone, Enchondroma cell line .a 5472 to 6197 740 to 19   AAA   722/722
(100 %)
4 diff
(99.5 %id)
TI_149277260   .a 5484 to 6202 816 to 99   AAA   718/718
(100 %)
3 diff
(99.6 %id)
CA419661 Bone, Human Chondrosarcoma Cell Line .a 5497 to 6202 727 to 19   AAA   709/709
(100 %)
4 diff
(99.5 %id)
CA419848 Bone, Human Chondrosarcoma Cell Line .a 5497 to 6185 710 to 19   AAA   692/692
(100 %)
4 diff
(99.5 %id)
TI_149283964   .a 5502 to 6202 788 to 89   AAA   700/701
(99 %)
1 diff
(99.9 %id)
TI_149286558   .a 5509 to 6186 788 to 108   AAA   681/682
(99 %)
8 diff
(98.9 %id)
BF247330 hypernephroma, Kidney .a 5513 to 6152 1 to 629   AAA   629/804
(78 %)
40 diff
(95.1 %id)
BF216483 brain, glioblastoma .a 5518 to 6152 1 to 629       629/806
(78 %)
34 diff
(95.8 %id)
CN404530 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 5526 to 6127 1 to 606       606/606
(100 %)
3 diff
(99.6 %id)
BU631293 cell lines, Chondrosarcoma .a 5533 to 6186 672 to 19   AAA   654/654
(100 %)
1 diff
(99.9 %id)
CA419338 Bone, Human Chondrosarcoma Cell Line .a 5535 to 6204 690 to 17   AAA   674/674
(100 %)
8 diff
(98.9 %id)
BM968232 lung, Primary Lung Epithelial Cells .a 5541 to 6197 679 to 19   AAA   661/662
(99 %)
3 diff
(99.6 %id)
BU687616 lung .a 5541 to 6202 680 to 19   AAA   662/663
(99 %)
0 diff
(100 %id)
BM984345 lung .a 5546 to 6202 675 to 19   AAA   657/657
(100 %)
0 diff
(100 %id)
BM972113 lung .a 5546 to 6186 663 to 19   AAA   645/645
(100 %)
6 diff
(99.1 %id)
BM968102 lung, Primary Lung Epithelial Cells .a 5564 to 6202 657 to 19   AAA   639/639
(100 %)
1 diff
(99.9 %id)
BU940204 mixed (pool of 40 RNAs) .a 5590 to 6179 1 to 596       596/859
(69 %)
26 diff
(97.0 %id)
H98103 melanocyte .a 5628 to 6204 579 to 1       579/580
(99 %)
7 diff
(98.8 %id)
N50357 multiple sclerosis lesions .a 5630 to 5770 1 to 141   fully sequenced,   141/141
(100 %)
1 diff
(99.3 %id)
BQ023786 placenta .a 5638 to 6202 583 to 19   AAA   565/565
(100 %)
1 diff
(99.9 %id)
TI_157600676   .a 5645 to 6197 641 to 87   AAA   555/782
(70 %)
21 diff
(97.4 %id)
AW270854 Kidney .a 5659 to 6133 475 to 1       475/475
(100 %)
2 diff
(99.6 %id)
BQ718453 sympathetic trunk .a 5664 to 6197 1 to 535       535/1037
(51 %)
6 diff
(99.5 %id)
AA431438   .a 5669 to 6192 536 to 13   AAA   524/524
(100 %)
2 diff
(99.7 %id)
AW003489 pooled germ cell tumors .a 5674 to 6200 541 to 13   AAA   529/529
(100 %)
15 diff
(97.2 %id)
AI435104 pooled .a 5705 to 6192 508 to 21   AAA   488/488
(100 %)
2 diff
(99.6 %id)
AA845537 parathyroid gland, parathyroid tumor .a 5707 to 6183 484 to 9       476/484
(98 %)
0 diff
(100 %id)
AI921419 adenocarcinoma, Pancreas .a 5710 to 6202 510 to 14   AAA   497/497
(100 %)
3 diff
(99.4 %id)
AI433228 lymph node, lymphoma, follicular mixed small and largecell .a 5719 to 6184 497 to 28   AAA   470/470
(100 %)
4 diff
(99.2 %id)
AI802905 pooled .a 5720 to 6197 488 to 11   AAA   478/478
(100 %)
0 diff
(100 %id)
AW130247 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 5721 to 6198 485 to 8       478/485
(98 %)
0 diff
(100 %id)
W46550 senescent fibroblast .a 5730 to 6197 489 to 15   AAA   475/478
(99 %)
26 diff
(94.6 %id)
AI921408 adenocarcinoma, Pancreas .a 5730 to 6202 490 to 14   AAA   477/477
(100 %)
3 diff
(99.4 %id)
AI925176 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 5733 to 6198 469 to 4       466/469
(99 %)
0 diff
(100 %id)
BX501450 Liver .a 5735 to 6204 492 to 21   AAA   472/472
(100 %)
2 diff
(99.6 %id)
CB044539 colon, juvenile granulosa tumor .a 5738 to 6233 5 to 500   tiling clone, fully sequenced, AAA   496/500
(99 %)
6 diff
(98.8 %id)
AI656521 pooled germ cell tumors .a 5743 to 6186 468 to 25   AAA   444/444
(100 %)
0 diff
(100 %id)
AA622938 lung, lung tumor .a 5746 to 6204 459 to 1       459/459
(100 %)
0 diff
(100 %id)
AI206961 pooled germ cell tumors .a 5760 to 6198 445 to 7       439/445
(98 %)
0 diff
(100 %id)
H97814 melanocyte .a 5764 to 6204 446 to 1       446/446
(100 %)
4 diff
(99.2 %id)
N51578 multiple sclerosis lesions .a 5766 to 6183 430 to 1   fully sequenced,   430/430
(100 %)
15 diff
(96.6 %id)
AI921424 adenocarcinoma, Pancreas .a 5771 to 6202 449 to 14   AAA   436/436
(100 %)
11 diff
(97.5 %id)
AI917752 pooled germ cell tumors .a 5781 to 6187 413 to 3       411/413
(99 %)
0 diff
(100 %id)
AW152553 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 5781 to 6204 447 to 21   AAA   427/427
(100 %)
9 diff
(97.9 %id)
AI889850 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 5782 to 6198 458 to 38   AAA   421/421
(100 %)
30 diff
(92.9 %id)
CB044538 colon, juvenile granulosa tumor .a 5782 to 6242 468 to 8   fully sequenced,   461/468
(98 %)
5 diff
(99.0 %id)
AW015359   .a 5784 to 6197 435 to 18   AAA   418/418
(100 %)
10 diff
(97.7 %id)
D29024   .a 5788 to 6192 1 to 400       400/410
(97 %)
11 diff
(97.4 %id)
AI619880 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 5788 to 6204 421 to 1       421/421
(100 %)
4 diff
(99.1 %id)
BF111586 pooled .a 5789 to 6201 426 to 15   AAA   412/419
(98 %)
2 diff
(99.6 %id)
BQ023073 placenta .a 5794 to 6197 422 to 19   AAA   404/404
(100 %)
2 diff
(99.6 %id)
BU565161 mixed (pool of 40 RNAs) .a 5800 to 6203 1 to 407       407/714
(57 %)
14 diff
(98.1 %id)
AW016004   .a 5805 to 6186 400 to 19   AAA   382/382
(100 %)
0 diff
(100 %id)
AI283944 esophagus, squamous cell carcinoma .a 5812 to 6197 390 to 1       390/390
(100 %)
3 diff
(99.3 %id)
C16187   .a 5816 to 6186 1 to 370       370/370
(100 %)
1 diff
(99.8 %id)
H99708 melanocyte .a 5818 to 6205 393 to 1       393/393
(100 %)
7 diff
(98.3 %id)
AW004631 colon .a 5821 to 6205 393 to 1       393/393
(100 %)
6 diff
(98.5 %id)
AI695876 pooled germ cell tumors .a 5823 to 6183 367 to 7       361/367
(98 %)
0 diff
(100 %id)
AI654989 pooled germ cell tumors .a 5823 to 6201 402 to 24   AAA   379/379
(100 %)
0 diff
(100 %id)
AA062588 pineal gland .a 5824 to 5943 295 to 421   fully sequenced,   368/368
(100 %)
12 diff
(96.8 %id)
N29389 melanocyte .a 5834 to 6204 381 to 1   fully sequenced,   381/381
(100 %)
3 diff
(99.3 %id)
AI340258 pooled germ cell tumors .a 5849 to 6186 351 to 12   AAA   340/344
(98 %)
4 diff
(98.9 %id)
AI829340 adenocarcinoma, Pancreas .a 5849 to 6204 384 to 27   AAA   358/363
(98 %)
7 diff
(98.1 %id)
AW168464 bowel (skin primary), metastatic melanoma to bowel .a 5861 to 6204 365 to 22   AAA   344/344
(100 %)
1 diff
(99.8 %id)
BF438832 pooled .a 5877 to 6208 336 to 3       334/336
(99 %)
0 diff
(100 %id)
N20885.
matches multiple genes
melanocyte .a 5892 to 6204 328 to 15   AAA also hits gene LEPROTL1 314/314
(100 %)
4 diff
(98.8 %id)
AA779637   .a 5894 to 6198 312 to 8       305/312
(97 %)
0 diff
(100 %id)
AA063061 pineal gland .a 5913 to 6197 286 to 1   fully sequenced,   286/286
(100 %)
1 diff
(99.7 %id)
AW295757   .a 5923 to 6202 299 to 18   AAA   282/284
(99 %)
3 diff
(99.0 %id)
AA782668 parathyroid gland, parathyroid tumor .a 5939 to 6192 274 to 21   AAA   254/254
(100 %)
0 diff
(100 %id)
AI745132 ovary, tumor, 5 pooled (see description) .a 5955 to 6198 244 to 1       244/247
(98 %)
0 diff
(100 %id)
BP396020 pancreatic islet .a 5958 to 6185 1 to 228     Submitted on the opposite strand 228/229
(99 %)
2 diff
(99.2 %id)
BF038974 adenocarcinoma, ovary .a 5988 to 6200 1 to 213       213/213
(100 %)
1 diff
(99.6 %id)
BU753325 placenta .a 5999 to 6197 216 to 18   AAA   199/199
(100 %)
0 diff
(100 %id)
BC029658 Prostate, adenocarcinoma. .b 1 to 3825 16 to 3842 exact tiling clone, available from MGC, AAA   3827/3842
(99 %)
10 diff
(99.8 %id)
TI_1948142418   .b 1222 to 2236 1136 to 127       1010/1340
(75 %)
28 diff
(98.0 %id)
TI_1948142078   .b 1284 to 2236 1082 to 131       951/1411
(67 %)
15 diff
(99.0 %id)
TI_1948142077   .b 1314 to 2236 1047 to 128       918/1360
(67 %)
18 diff
(98.7 %id)
TI_1948142419   .b 1314 to 2236 1059 to 131       929/1314
(70 %)
27 diff
(98.0 %id)
TI_1948142753   .b 1314 to 2236 1048 to 129       920/1359
(67 %)
10 diff
(99.3 %id)
TI_1948141754   .b 1315 to 2236 1045 to 127       919/1284
(71 %)
19 diff
(98.6 %id)
TI_1948142754   .b 1359 to 2236 1010 to 130       881/1364
(64 %)
11 diff
(99.2 %id)
TI_1948141755   .b 1442 to 2236 924 to 131       794/1275
(62 %)
7 diff
(99.5 %id)
NM_080927.3   .c 1 to 6496 1 to 6093 exact RefSeq,   6093/6093
(100 %)
0 diff
(100 %id)
DA705103   .c 9 to 275 2 to 270   tiling clone, capped   269/270
(99 %)
4 diff
(98.6 %id)
BG433690 Kidney .c 27 to 538 1 to 516       516/517
(99 %)
33 diff
(93.7 %id)
AI262981 Kidney .c 52 to 431 380 to 1   tiling clone,   380/380
(100 %)
1 diff
(99.8 %id)
AI864669 pooled .c 63 to 397 335 to 1       335/335
(100 %)
1 diff
(99.8 %id)
AI220745 placenta .c 223 to 431 209 to 1       209/209
(100 %)
0 diff
(100 %id)
CN404526 embryonic stem cells, cell lines H1, H7, andH9 .c 395 to 725 1 to 331       331/331
(100 %)
0 diff
(100 %id)
H99544 melanocyte .c 424 to 793 1 to 377     Submitted on the opposite strand 377/418
(90 %)
11 diff
(97.4 %id)
TI_157603381   .c 424 to 942 89 to 607   tiling clone, Submitted on the opposite strand 519/631
(82 %)
12 diff
(98.1 %id)
TI_157604945   .c 424 to 942 60 to 578     Submitted on the opposite strand 519/591
(87 %)
19 diff
(96.8 %id)
AI499115 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 432 to 934 1 to 502     Submitted on the opposite strand 502/502
(100 %)
0 diff
(100 %id)
AI767271 Kidney .c 433 to 902 1 to 470     Submitted on the opposite strand 470/470
(100 %)
2 diff
(99.6 %id)
H85099 eye, retina .c 468 to 776 1 to 316     Submitted on the opposite strand 316/388
(81 %)
8 diff
(98.0 %id)
H80005 eye, retina .c 514 to 797 1 to 290     Submitted on the opposite strand 290/332
(87 %)
8 diff
(97.6 %id)
BF762975 colon_est .c 820 to 1337 1 to 506   tiling clone,   506/506
(100 %)
15 diff
(97.1 %id)
DA460446 tongue, tumor tissue .c 1372 to 1938 2 to 568   tiling clone, capped   567/567
(100 %)
0 diff
(100 %id)
H99543 melanocyte .c 1387 to 1825 439 to 1     Submitted on the opposite strand 439/439
(100 %)
5 diff
(98.9 %id)
BP277772   .c 1441 to 2020 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BP277823   .c 1441 to 2023 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
H80004 eye, retina .c 1464 to 1818 361 to 1     Submitted on the opposite strand 361/437
(82 %)
7 diff
(98.4 %id)
M91216   .c 1489 to 1756 276 to 11   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 266/276
(96 %)
0 diff
(100 %id)
CD636035   .c 1541 to 1891 8 to 357       350/358
(97 %)
10 diff
(97.3 %id)
CD636036   .c 1541 to 1887 345 to 1       345/352
(98 %)
4 diff
(98.9 %id)
CD636039   .c 1541 to 1891 8 to 358       351/359
(97 %)
7 diff
(98.1 %id)
CD636040   .c 1541 to 1891 351 to 1       351/358
(98 %)
0 diff
(100 %id)
CD636041   .c 1541 to 1891 8 to 358       351/359
(97 %)
8 diff
(97.8 %id)
CD636042   .c 1541 to 1889 349 to 2       348/356
(97 %)
2 diff
(99.5 %id)
CD636043   .c 1541 to 1891 8 to 358       351/359
(97 %)
7 diff
(98.1 %id)
CD636044   .c 1541 to 1854 315 to 3       313/322
(97 %)
0 diff
(100 %id)
BE894226 melanotic melanoma, skin .c 1611 to 2227 1 to 618       618/618
(100 %)
3 diff
(99.6 %id)
BG748212 eye, normal pigmented retinal epithelium .c 1641 to 2112 1 to 459       459/459
(100 %)
43 diff
(90.7 %id)
BI860608 breast, mammary adenocarcinoma, cell line .c 1653 to 2338 9 to 694       686/694
(98 %)
6 diff
(99.2 %id)
TI_57189490   .c 1653 to 2338 66 to 751       686/694
(98 %)
6 diff
(99.2 %id)
CN404532 embryonic stem cells, cell lines H1, H7, andH9 .c 1676 to 2365 1 to 691       691/691
(100 %)
1 diff
(99.9 %id)
BX473031   .c 1678 to 2184 1 to 507       507/507
(100 %)
3 diff
(99.5 %id)
DA544019   .c 1700 to 2256 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
AL046164 testis .c 1713 to 2133 1 to 422       422/422
(100 %)
3 diff
(99.3 %id)
AI378788 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1718 to 2429 712 to 1       712/712
(100 %)
12 diff
(98.4 %id)
AW383902 head_neck .c 1721 to 2286 6 to 572       567/575
(98 %)
25 diff
(95.7 %id)
CD636037   .c 1758 to 1891 1 to 134       134/135
(99 %)
6 diff
(95.6 %id)
CD636038   .c 1765 to 1854 103 to 14       90/110
(81 %)
0 diff
(100 %id)
AI435602 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1788 to 2429 640 to 1       640/641
(99 %)
4 diff
(99.4 %id)
DA030298   .c 1878 to 2226 2 to 350   capped   349/349
(100 %)
0 diff
(100 %id)
CN404528 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1888 to 2524 1 to 637   tiling clone,   637/637
(100 %)
0 diff
(100 %id)
DB323937   .c 1891 to 2430 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
AI417256 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1895 to 2429 535 to 1       535/535
(100 %)
2 diff
(99.7 %id)
AI290500 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1913 to 2429 525 to 1       525/525
(100 %)
16 diff
(97.0 %id)
AI436734 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1940 to 2114 175 to 1       175/175
(100 %)
7 diff
(96.0 %id)
AI276772 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1976 to 2429 454 to 1       454/457
(99 %)
4 diff
(99.2 %id)
BP280478   .c 1981 to 2608 1 to 628       628/628
(100 %)
0 diff
(100 %id)
BE082931 breast .c 2001 to 2131 154 to 24     Submitted on the opposite strand 131/159
(82 %)
0 diff
(100 %id)
AI242761 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2036 to 2430 395 to 1       395/395
(100 %)
0 diff
(100 %id)
AA233072 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2101 to 2430 329 to 1       329/329
(100 %)
1 diff
(99.7 %id)
BP278438   .c 2145 to 2726 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CN404521 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 2184 to 2868 1 to 684       684/684
(100 %)
3 diff
(99.6 %id)
BM450083 melanotic melanoma, skin .c 2219 to 3157 1 to 951       951/1065
(89 %)
23 diff
(97.9 %id)
DA026088   .c 2262 to 2825 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA548286   .c 2341 to 2861 2 to 525   capped   524/524
(100 %)
5 diff
(99.1 %id)
BE925427 amnion_normal .c 2372 to 2692 1 to 317       317/317
(100 %)
6 diff
(98.2 %id)
BU171889 melanotic melanoma, skin .c 2419 to 3275 1 to 862   tiling clone,   862/862
(100 %)
9 diff
(99.0 %id)
BQ014739 Chondrosarcoma, Left Pubic Bone .c 2480 to 3136 680 to 24       657/680
(96 %)
0 diff
(100 %id)
CN404518 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 2600 to 3222 1 to 624       624/624
(100 %)
3 diff
(99.6 %id)
DB241187 trachea .c 2603 to 3193 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
DA486796 brain .c 2629 to 3200 2 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
CN404510 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 2634 to 3222 7 to 597       591/597
(98 %)
6 diff
(99.0 %id)
CB144123 Liver .c 2680 to 3071 1 to 392       392/392
(100 %)
0 diff
(100 %id)
CN404522 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2723 to 3145 1 to 424       424/424
(100 %)
1 diff
(99.8 %id)
AW583777 Islets of Langerhans, Pancreas .c 2731 to 2834 1 to 104       104/104
(100 %)
0 diff
(100 %id)
CN404507 embryonic stem cells, DMSO-treated H9 cellline .c 2742 to 3169 1 to 429       429/429
(100 %)
4 diff
(99.1 %id)
CN404529 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2798 to 3325 1 to 529       529/529
(100 %)
2 diff
(99.7 %id)
AL705213 human skeletal muscle .c 2811 to 3457 1 to 647       647/647
(100 %)
2 diff
(99.7 %id)
DB239324 trachea .c 2814 to 3385 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
DA213247 brain .c 2867 to 3412 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
BP267549 thyroid .c 2902 to 3479 7 to 585       579/587
(98 %)
2 diff
(99.7 %id)
CN404534 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 2951 to 3430 1 to 481       481/481
(100 %)
4 diff
(99.2 %id)
BP265268 thyroid .c 2964 to 3544 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BF037277 adenocarcinoma, ovary .c 3053 to 3770 1 to 730       730/942
(77 %)
16 diff
(98.4 %id)
BE178110 head_neck .c 3080 to 3713 14 to 647       634/647
(97 %)
6 diff
(99.1 %id)
CN404514 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 3097 to 3573 1 to 479       479/479
(100 %)
1 diff
(99.8 %id)
DA162625 amygdala .c 3111 to 3689 2 to 580   tiling clone, capped   579/579
(100 %)
2 diff
(99.7 %id)
BP240459 Liver .c 3156 to 3732 1 to 577       577/577
(100 %)
13 diff
(97.8 %id)
DB143169 thymus .c 3179 to 3712 2 to 536   capped   535/535
(100 %)
5 diff
(99.1 %id)
CN404516 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 3182 to 3639 1 to 461       461/461
(100 %)
5 diff
(99.0 %id)
DA862663 placenta .c 3256 to 3788 2 to 537   capped   536/536
(100 %)
4 diff
(99.3 %id)
BE093784 breast .c 3325 to 3479 1 to 156       156/156
(100 %)
1 diff
(99.4 %id)
BF572644 melanotic melanoma, high MDR, skin .c 3326 to 3917 1 to 597       597/631
(94 %)
32 diff
(95.0 %id)
BU159109 epithelioid carcinoma, Pancreas .c 3328 to 4186 1 to 861       861/863
(99 %)
10 diff
(98.9 %id)
AW298001   .c 3335 to 3778 472 to 29       444/472
(94 %)
0 diff
(100 %id)
BE176120 head_neck .c 3367 to 3648 13 to 295       283/305
(92 %)
5 diff
(98.4 %id)
AI568869 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 3391 to 3818 439 to 12   AAA   428/428
(100 %)
1 diff
(99.8 %id)
AK001362   .c 3402 to 6488 1 to 3086   tiling clone, available from FLJ,   3086/3086
(100 %)
4 diff
(99.9 %id)
AU127004   .c 3403 to 4138 2 to 737   capped   736/737
(99 %)
11 diff
(98.6 %id)
AA308478 colon .c 3428 to 3770 1 to 343       343/344
(99 %)
1 diff
(99.8 %id)
AL600192   .c 3473 to 4001 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
BG431284 Kidney .c 3474 to 4273 1 to 797       797/797
(100 %)
16 diff
(98.0 %id)
CD694492 normal nasopharynx .c 3483 to 4071 39 to 627       589/627
(93 %)
6 diff
(99.1 %id)
BM468461 melanotic melanoma, skin .c 3495 to 4430 1 to 946   tiling clone,   946/1007
(93 %)
19 diff
(98.2 %id)
BQ424874 melanotic melanoma, skin .c 3516 to 4277 12 to 776       765/916
(83 %)
6 diff
(99.4 %id)
DA660202   .c 3542 to 4121 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
CN404519 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 3574 to 4249 1 to 677       677/677
(100 %)
5 diff
(99.3 %id)
W24316 senescent fibroblast .c 3620 to 4104 1 to 487       487/487
(100 %)
2 diff
(99.6 %id)
CN404533 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 3628 to 4172 1 to 546       546/546
(100 %)
4 diff
(99.3 %id)
AA090038   .c 3633 to 3975 1 to 336       336/336
(100 %)
16 diff
(95.3 %id)
DA516805 brain .c 3710 to 4248 2 to 541   capped   540/540
(100 %)
1 diff
(99.9 %id)
CN404535 embryonic stem cells, cell lines H1, H7, andH9 .c 3713 to 4403 1 to 690       690/690
(100 %)
4 diff
(99.5 %id)
BQ901027 sympathetic trunk .c 3775 to 4335 1 to 565       565/949
(59 %)
19 diff
(98.0 %id)
BF031523 hypernephroma, Kidney .c 3782 to 4296 1 to 520       520/623
(83 %)
8 diff
(98.8 %id)
DA024721   .c 3793 to 4356 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA751984   .c 3803 to 4308 2 to 509   capped   508/508
(100 %)
3 diff
(99.5 %id)
CA392787 eye, RPE/choroid .c 3815 to 4444 1 to 630       630/630
(100 %)
2 diff
(99.7 %id)
BP332440 renal proximal tubule .c 3822 to 4400 1 to 579       579/580
(99 %)
19 diff
(96.8 %id)
AA304469 aorta .c 3828 to 4172 1 to 345       345/345
(100 %)
0 diff
(100 %id)
AW954789   .c 3829 to 4435 1 to 607       607/607
(100 %)
7 diff
(98.9 %id)
DB013597 esophageal, tumor tissue .c 3832 to 4308 2 to 478   capped   477/477
(100 %)
1 diff
(99.8 %id)
CN404525 embryonic stem cells, DMSO-treated H9 cellline .c 3839 to 4479 9 to 650       642/650
(98 %)
6 diff
(99.1 %id)
AF104313 foreskin .c 3859 to 6488 1 to 2631   AAA   2631/2631
(100 %)
21 diff
(99.3 %id)
BE004769 breast_normal .c 3926 to 4143 1 to 217       217/217
(100 %)
14 diff
(93.6 %id)
DA784844 brain .c 3948 to 4520 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BE004912 breast_normal .c 3957 to 4155 1 to 200       200/202
(99 %)
6 diff
(97.1 %id)
DA546799   .c 3966 to 4535 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA653420   .c 3978 to 4523 2 to 547   capped   546/546
(100 %)
2 diff
(99.7 %id)
BX473762   .c 3980 to 4685 1 to 707       707/707
(100 %)
4 diff
(99.5 %id)
DA655286   .c 3980 to 4549 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
CV569408 cornea, eye .c 4000 to 4520 1 to 521       521/521
(100 %)
1 diff
(99.9 %id)
BQ009910 Chondrosarcoma, Left Pubic Bone .c 4002 to 4682 699 to 19   AAA   681/681
(100 %)
3 diff
(99.6 %id)
BF132248 hypernephroma, Kidney .c 4023 to 4679 1 to 647       647/792
(81 %)
29 diff
(96.4 %id)
DA301169 hippocampus .c 4033 to 4600 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BG171181 hypernephroma, cell line, Kidney .c 4040 to 4752 1 to 711       711/921
(77 %)
14 diff
(98.5 %id)
DA542659   .c 4090 to 4778 2 to 690   capped   689/693
(99 %)
5 diff
(99.3 %id)
TI_149305220   .c 4097 to 4682 671 to 86   AAA   586/962
(60 %)
2 diff
(99.8 %id)
BU685600 lung, Primary Lung Epithelial Cells .c 4097 to 4682 603 to 18   AAA   586/594
(98 %)
2 diff
(99.7 %id)
CN478765 Human Lung Epithelial cells, lung .c 4097 to 4682 604 to 19   AAA   586/595
(98 %)
1 diff
(99.9 %id)
AA883517 pooled .c 4145 to 4519 1 to 375     Submitted on the opposite strand 375/375
(100 %)
1 diff
(99.8 %id)
BG779576 adenocarcinoma, Prostate .c 4149 to 4991 1 to 840       840/888
(94 %)
35 diff
(96.1 %id)
DA021902   .c 4154 to 4717 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BU164131 epithelioid carcinoma, Pancreas .c 4159 to 4682 1 to 524       524/528
(99 %)
2 diff
(99.7 %id)
DA718158   .c 4185 to 4695 2 to 513   capped   512/512
(100 %)
2 diff
(99.7 %id)
BM743131 stomach .c 4218 to 4682 1 to 465   AAA   465/465
(100 %)
1 diff
(99.8 %id)
DB520356 testis .c 4242 to 4682 1 to 441   AAA Submitted on the opposite strand 441/441
(100 %)
1 diff
(99.8 %id)
AI080244 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 4266 to 4683 425 to 8       418/425
(98 %)
0 diff
(100 %id)
AW078727 lung, cell line .c 4270 to 4685 429 to 13   AAA   417/417
(100 %)
3 diff
(99.3 %id)
DA547278   .c 4271 to 4829 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
BQ072345 pooled lung and spleen .c 4310 to 5313 16 to 1029       1014/1031
(98 %)
35 diff
(96.7 %id)
N36456 melanocyte .c 4387 to 4830 1 to 448       448/464
(96 %)
8 diff
(98.3 %id)
DA601368   .c 4398 to 4811 2 to 420   capped   419/425
(98 %)
7 diff
(98.4 %id)
W07366 lung .c 4399 to 4829 1 to 443       443/533
(83 %)
17 diff
(96.9 %id)
BF033517 adenocarcinoma, ovary .c 4447 to 4679 1 to 234       234/234
(100 %)
1 diff
(99.6 %id)
BP223945 colon mucosa .c 4457 to 5162 1 to 713       713/720
(99 %)
16 diff
(97.8 %id)
BF216788 brain, glioblastoma .c 4459 to 5105 1 to 638       638/746
(85 %)
17 diff
(97.8 %id)
DA548456   .c 4485 to 5062 2 to 582   capped   581/581
(100 %)
5 diff
(99.2 %id)
BP269871 thyroid .c 4493 to 5073 1 to 580       580/584
(99 %)
2 diff
(99.7 %id)
BP197877 adrenal gland .c 4501 to 5078 1 to 578       578/582
(99 %)
20 diff
(96.6 %id)
EH344585   .c 4502 to 4573 1 to 72       72/72
(100 %)
0 diff
(100 %id)
BQ893624 dorsal root ganglia .c 4510 to 5322 32 to 850       819/974
(84 %)
10 diff
(99.0 %id)
BP204125 coronary artery .c 4521 to 5080 1 to 560       560/560
(100 %)
3 diff
(99.5 %id)
BF327541 breast_normal .c 4541 to 4690 1 to 152       152/152
(100 %)
7 diff
(95.4 %id)
CX868016 embryonic stem .c 4558 to 5324 1 to 768       768/768
(100 %)
1 diff
(99.9 %id)
DA597808   .c 4563 to 5121 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
AA247776   .c 4572 to 4704 1 to 133       133/135
(98 %)
4 diff
(97.1 %id)
BP205567 coronary artery .c 4593 to 5176 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
BF969299 adrenal cortex carcinoma, cell line, adrenal gland .c 4641 to 5157 1 to 548       548/911
(60 %)
66 diff
(92.8 %id)
BU182750 melanotic melanoma, skin .c 4644 to 5239 1 to 599       599/1036
(57 %)
15 diff
(98.6 %id)
CN404520 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 4712 to 5147 7 to 442       436/442
(98 %)
6 diff
(98.7 %id)
BG119190 adenocarcinoma, cell line, Liver .c 4778 to 5418 8 to 634       627/884
(70 %)
41 diff
(95.4 %id)
CN483174 eye .c 4782 to 5413 1 to 633       633/633
(100 %)
1 diff
(99.9 %id)
BG120516 adenocarcinoma, cell line, Liver .c 4782 to 5337 13 to 568       556/706
(78 %)
6 diff
(99.2 %id)
CX784476 human embryonic stem cells .c 4784 to 5522 1 to 739       739/739
(100 %)
2 diff
(99.8 %id)
CN404509 embryonic stem cells, cell lines H1, H7, andH9 .c 4803 to 5323 1 to 520       520/520
(100 %)
2 diff
(99.7 %id)
BI869263 adenocarcinoma, cell line, Liver .c 4816 to 5409 1 to 595       595/721
(82 %)
16 diff
(97.8 %id)
TI_57231278   .c 4816 to 5409 90 to 684       595/721
(82 %)
16 diff
(97.8 %id)
AA093400   .c 4820 to 5064 1 to 245       245/246
(99 %)
4 diff
(98.4 %id)
FN061341 breast carcinoma .c 4852 to 4954 1 to 103       103/103
(100 %)
0 diff
(100 %id)
FN075609 breast carcinoma .c 4852 to 4950 1 to 96       96/96
(100 %)
3 diff
(96.9 %id)
CN404523 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 4905 to 5412 1 to 508       508/508
(100 %)
0 diff
(100 %id)
R53270 whole brain .c 4906 to 5303 1 to 398       398/398
(100 %)
0 diff
(100 %id)
H29363 whole brain .c 4907 to 5273 1 to 367       367/367
(100 %)
3 diff
(99.2 %id)
BP204797 coronary artery .c 4916 to 5496 1 to 587       587/587
(100 %)
11 diff
(98.2 %id)
CN404512 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 5001 to 5262 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BM726923 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 5014 to 5684 1 to 670       670/670
(100 %)
3 diff
(99.6 %id)
AA344259 gall bladder .c 5033 to 5278 1 to 245       245/245
(100 %)
1 diff
(99.6 %id)
AW963065   .c 5034 to 5723 1 to 689       689/690
(99 %)
20 diff
(97.2 %id)
BP205336 coronary artery .c 5064 to 5637 1 to 572       572/572
(100 %)
14 diff
(97.6 %id)
BQ429972 melanotic melanoma, skin .c 5070 to 5782 1 to 716       716/918
(77 %)
30 diff
(96.8 %id)
BU928488 brain, glioblastoma .c 5102 to 5833 1 to 748       748/806
(92 %)
26 diff
(96.8 %id)
AU118906 whole embryo, mainly head .c 5105 to 5871 2 to 768   capped   767/769
(99 %)
8 diff
(99.0 %id)
CN404515 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 5146 to 5532 1 to 385       385/385
(100 %)
3 diff
(99.3 %id)
BU076501 Pancreas, Purified pancreatic islet .c 5158 to 5762 602 to 1   tiling clone, Submitted on the opposite strand 602/602
(100 %)
3 diff
(99.6 %id)
CN404508 embryonic stem cells, cell lines H1, H7, andH9 .c 5169 to 5525 23 to 381       359/381
(94 %)
6 diff
(98.5 %id)
CN404513 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 5171 to 5525 1 to 354       354/354
(100 %)
1 diff
(99.8 %id)
BG171744 hypernephroma, cell line, Kidney .c 5179 to 5804 29 to 661       633/967
(65 %)
36 diff
(96.3 %id)
AU123710   .c 5225 to 6041 2 to 819   capped   818/818
(100 %)
9 diff
(98.9 %id)
BF928885 nervous_tumor .c 5245 to 5607 375 to 15     Submitted on the opposite strand 361/395
(91 %)
0 diff
(100 %id)
BX111796 melanocyte .c 5264 to 5945 1 to 681       681/681
(100 %)
3 diff
(99.6 %id)
BU569853 testis .c 5270 to 5956 1 to 691       691/737
(93 %)
12 diff
(98.4 %id)
BE876523 large cell carcinoma, undifferentiated, lung .c 5280 to 6047 1 to 756       756/930
(81 %)
55 diff
(94.1 %id)
AA548373 germ cell tumor .c 5292 to 5751 465 to 6       460/465
(98 %)
0 diff
(100 %id)
N40058 melanocyte .c 5305 to 5642 1 to 337       337/337
(100 %)
3 diff
(99.2 %id)
BQ310780 breast_normal .c 5326 to 5567 257 to 20       238/257
(92 %)
0 diff
(100 %id)
BE002153 breast_normal .c 5397 to 5711 339 to 25     Submitted on the opposite strand 315/369
(85 %)
0 diff
(100 %id)
BF091546 testis_normal .c 5401 to 5709 310 to 1       310/629
(49 %)
5 diff
(99.3 %id)
BM994301 lung, Metastatic Chondrosarcoma .c 5412 to 6098 1 to 687   AAA Submitted on the opposite strand 687/687
(100 %)
1 diff
(99.9 %id)
BU607894 Human Lung Epithelial cells, lung .c 5412 to 6110 1 to 698   AAA Submitted on the opposite strand 698/701
(99 %)
4 diff
(99.5 %id)
AA767667 germinal center B cell .c 5421 to 5929 1 to 509     Submitted on the opposite strand 509/509
(100 %)
1 diff
(99.9 %id)
AA768485 germinal center B cell .c 5421 to 5795 1 to 374     Submitted on the opposite strand 374/374
(100 %)
4 diff
(99.0 %id)
AA805633 germinal center B cell .c 5421 to 5935 1 to 513     Submitted on the opposite strand 513/513
(100 %)
3 diff
(99.5 %id)
AA074721   .c 5422 to 5873 1 to 459       459/464
(98 %)
12 diff
(97.5 %id)
BE002163 breast_normal .c 5426 to 5711 307 to 19     Submitted on the opposite strand 289/307
(94 %)
0 diff
(100 %id)
AI379718   .c 5426 to 5878 1 to 453     Submitted on the opposite strand 453/453
(100 %)
0 diff
(100 %id)
AA341724 Kidney .c 5430 to 5663 1 to 234       234/234
(100 %)
0 diff
(100 %id)
FN152063 breast carcinoma .c 5430 to 5503 1 to 73       73/73
(100 %)
1 diff
(98.7 %id)
AA975331 carcinoid, lung .c 5431 to 5756 1 to 326     Submitted on the opposite strand 326/326
(100 %)
1 diff
(99.7 %id)
BE222036 carcinoid, lung .c 5431 to 5913 1 to 483     Submitted on the opposite strand 483/483
(100 %)
2 diff
(99.6 %id)
BE465402 carcinoid, lung .c 5431 to 5916 1 to 486     Submitted on the opposite strand 486/486
(100 %)
1 diff
(99.8 %id)
BP372176 umbilical cord .c 5453 to 6032 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BG170753 hypernephroma, cell line, Kidney .c 5457 to 6200 13 to 755       743/884
(84 %)
9 diff
(99.0 %id)
R62694 placenta .c 5465 to 5824 1 to 366       366/425
(86 %)
8 diff
(98.2 %id)
CN404506 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 5483 to 6158 1 to 675       675/675
(100 %)
4 diff
(99.5 %id)
BE904348 epithelioid carcinoma, Pancreas .c 5483 to 6064 583 to 1     Submitted on the opposite strand 583/862
(67 %)
4 diff
(99.6 %id)
T85138 liver and spleen .c 5485 to 5839 14 to 378       365/385
(94 %)
16 diff
(95.9 %id)
H63659 liver and spleen .c 5485 to 5900 1 to 423       423/423
(100 %)
12 diff
(97.2 %id)
BE005658 breast_normal .c 5486 to 5693 1 to 208       208/208
(100 %)
16 diff
(92.4 %id)
W87627 liver and spleen .c 5486 to 5806 1 to 322       322/333
(96 %)
3 diff
(99.1 %id)
W00339.
matches multiple genes
melanocyte .c 5489 to 5791 1 to 309     also hits gene CHCHD5 309/398
(77 %)
7 diff
(98.3 %id)
BE871752 adenocarcinoma, colon .c 5493 to 6151 1 to 656       656/857
(76 %)
21 diff
(97.6 %id)
TI_154059744   .c 5528 to 6476 1031 to 90   AAA   942/1028
(91 %)
12 diff
(98.9 %id)
EL946084 eyeball .c 5542 to 6092 1 to 551       551/551
(100 %)
0 diff
(100 %id)
R06174 liver and spleen .c 5542 to 5713 1 to 174       174/176
(98 %)
6 diff
(96.6 %id)
N40647 melanocyte .c 5542 to 5941 1 to 406       406/409
(99 %)
13 diff
(96.9 %id)
N45041 melanocyte .c 5542 to 5767 1 to 231       231/236
(97 %)
8 diff
(96.7 %id)
W02994 melanocyte .c 5548 to 5697 1 to 150       150/151
(99 %)
1 diff
(99.4 %id)
TI_154033826   .c 5577 to 6483 926 to 28   AAA   899/958
(93 %)
23 diff
(97.6 %id)
AV682179 hepatocellular carcinoma .c 5589 to 6261 673 to 1     Submitted on the opposite strand 673/675
(99 %)
4 diff
(99.5 %id)
BE878998 large cell carcinoma, undifferentiated, lung .c 5594 to 6288 1 to 690       690/691
(99 %)
14 diff
(98.0 %id)
BU624320 cell lines, Enchondroma .c 5608 to 6278 689 to 15   AAA   675/675
(100 %)
15 diff
(97.8 %id)
TI_149273802   .c 5609 to 6488 977 to 101   AAA   877/881
(99 %)
23 diff
(97.4 %id)
CN404517 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 5611 to 5862 1 to 252       252/252
(100 %)
0 diff
(100 %id)
BG929057 cartilage .c 5615 to 6161 79 to 625       547/556
(98 %)
7 diff
(98.8 %id)
W35107 heart .c 5626 to 6078 1 to 457       457/458
(99 %)
6 diff
(98.7 %id)
FN169311 breast carcinoma .c 5627 to 5735 105 to 1     Submitted on the opposite strand 105/105
(100 %)
4 diff
(96.2 %id)
TI_154193118   .c 5634 to 6492 46 to 898   AAA   853/853
(100 %)
25 diff
(97.1 %id)
CF127581 Chondrosarcoma Lung Metastasis cell lines, lung .c 5635 to 6420 1 to 788       788/789
(99 %)
12 diff
(98.5 %id)
BF381606 brain, primitive neuroectoderm .c 5642 to 6162 1 to 524       524/824
(63 %)
19 diff
(97.7 %id)
BE176208 head_neck .c 5647 to 6076 23 to 453       431/453
(95 %)
6 diff
(98.7 %id)
TI_149309200   .c 5649 to 6493 930 to 90   AAA   841/979
(85 %)
12 diff
(98.8 %id)
R31073 placenta .c 5650 to 6036 1 to 392       392/476
(82 %)
5 diff
(99.0 %id)
BE708542 head_neck .c 5660 to 5859 1 to 200       200/200
(100 %)
0 diff
(100 %id)
BU858882 mixed (pool of 40 RNAs) .c 5666 to 6274 1 to 609       609/613
(99 %)
4 diff
(99.4 %id)
BF793606 adrenal cortex carcinoma, cell line, adrenal gland .c 5676 to 6296 1 to 616   AAA   616/616
(100 %)
9 diff
(98.6 %id)
BE000426 breast_normal .c 5678 to 5859 1 to 181       181/181
(100 %)
4 diff
(97.8 %id)
BC016815 Brain, glioblastoma .c 5678 to 6482 1 to 809   available from MGC, AAA   809/809
(100 %)
6 diff
(99.3 %id)
BF215935 brain, glioblastoma .c 5681 to 6195 1 to 513       513/516
(99 %)
5 diff
(99.1 %id)
BE738054 brain, glioblastoma .c 5707 to 6258 1 to 547       547/547
(100 %)
15 diff
(97.3 %id)
DA262363 caudate nucleus .c 5728 to 6286 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
FN143313 breast carcinoma .c 5752 to 5852 101 to 1     Submitted on the opposite strand 101/101
(100 %)
1 diff
(99.1 %id)
CX867936 embryonic stem .c 5816 to 6494 704 to 26   AAA   679/679
(100 %)
2 diff
(99.8 %id)
AA722799 heart .c 5825 to 6297 478 to 2       477/478
(99 %)
0 diff
(100 %id)
BP224299 colon mucosa .c 5826 to 6143 1 to 318       318/324
(98 %)
1 diff
(99.7 %id)
BP224306 colon mucosa .c 5826 to 6146 1 to 321       321/325
(98 %)
2 diff
(99.4 %id)
AI191794   .c 5827 to 6297 475 to 4       472/475
(99 %)
0 diff
(100 %id)
AI498493 Kidney .c 5829 to 6297 473 to 1       473/473
(100 %)
3 diff
(99.4 %id)
AW001619 Kidney .c 5840 to 6296 462 to 1       462/462
(100 %)
5 diff
(99.0 %id)
BE088851 breast .c 5866 to 6227 372 to 2     Submitted on the opposite strand 371/372
(99 %)
0 diff
(100 %id)
BE088922 breast .c 5866 to 6227 372 to 2     Submitted on the opposite strand 371/372
(99 %)
0 diff
(100 %id)
AW134557   .c 5875 to 6298 443 to 16   AAA   428/428
(100 %)
3 diff
(99.3 %id)
BU741198 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 5883 to 6477 613 to 19   AAA   595/595
(100 %)
0 diff
(100 %id)
AL705214 human skeletal muscle .c 5901 to 6493 612 to 20   AAA   593/593
(100 %)
1 diff
(99.9 %id)
BM714569 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 5903 to 6296 1 to 394   AAA   394/394
(100 %)
0 diff
(100 %id)
AU145359 whole embryo, mainly head .c 5920 to 6488 568 to 1       568/570
(99 %)
13 diff
(97.8 %id)
AI886511 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 5922 to 6296 375 to 1       375/375
(100 %)
2 diff
(99.5 %id)
AI689085 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 5947 to 6296 385 to 36   AAA   350/350
(100 %)
10 diff
(97.2 %id)
AU149735   .c 5964 to 6488 523 to 1       523/527
(99 %)
12 diff
(97.8 %id)
AA128780   .c 5984 to 6291 1 to 310   fully sequenced,   310/310
(100 %)
3 diff
(99.1 %id)
N25742 melanocyte .c 6028 to 6483 461 to 1       461/461
(100 %)
4 diff
(99.2 %id)
AA075228   .c 6060 to 6494 438 to 1       438/438
(100 %)
3 diff
(99.4 %id)
N35032 melanocyte .c 6069 to 6488 424 to 1       424/424
(100 %)
3 diff
(99.3 %id)
N27122 melanocyte .c 6087 to 6493 410 to 1       410/411
(99 %)
3 diff
(99.3 %id)
W87628 liver and spleen .c 6093 to 6488 406 to 1       406/406
(100 %)
8 diff
(98.1 %id)
N73012 melanocyte .c 6095 to 6499 407 to 2       406/408
(99 %)
0 diff
(100 %id)
W23674 heart .c 6107 to 6488 392 to 1       392/399
(98 %)
6 diff
(98.5 %id)
T25097   .c 6125 to 6297 179 to 3       177/179
(98 %)
0 diff
(100 %id)
AA128681   .c 6134 to 6297 164 to 1   fully sequenced,   164/164
(100 %)
0 diff
(100 %id)
N81075 lung .c 6163 to 6490 331 to 1       331/331
(100 %)
3 diff
(99.1 %id)
R52616 whole brain .c 6190 to 6492 319 to 22   AAA   298/304
(98 %)
3 diff
(99.1 %id)
R62641 placenta .c 6200 to 6489 291 to 1       291/291
(100 %)
1 diff
(99.7 %id)
T88700 liver and spleen .c 6210 to 6483 274 to 1       274/275
(99 %)
1 diff
(99.7 %id)
R31553 placenta .c 6216 to 6457 242 to 1       242/242
(100 %)
3 diff
(98.8 %id)
BP421768 small intestine .c 6296 to 6478 1 to 183     Submitted on the opposite strand 183/186
(98 %)
1 diff
(99.5 %id)
FN055176 breast carcinoma .c 6316 to 6425 110 to 1     Submitted on the opposite strand 110/110
(100 %)
0 diff
(100 %id)
N71977 melanocyte .c 6363 to 6495 133 to 1   tiling clone,   133/133
(100 %)
0 diff
(100 %id)
BU634176 cell lines, Chondrosarcoma .d 1 to 775 785 to 19 D2C Q5R K6N W7D T8V ... tiling clone, AAA   767/767
(100 %)
13 diff
(98.4 %id)
AI302412 2 pooled tumors (clear cell type), Kidney .d 371 to 782 414 to 3   tiling clone,   412/414
(99 %)
1 diff
(99.8 %id)
BF511859   .d 436 to 775 357 to 18   AAA   340/340
(100 %)
1 diff
(99.8 %id)
BP280141   .e 1 to 606 1 to 607 E55R R56E V57S R58S I59H ... tiling clone,   607/607
(100 %)
10 diff
(98.4 %id)
BP363674 lung .f 1 to 585 1 to 583 S86K K87V Y88L C89P P90S ... tiling clone,   583/583
(100 %)
2 diff
(99.7 %id)
BP278574   .g 1 to 583 1 to 583 E95G tiling clone,   583/583
(100 %)
2 diff
(99.7 %id)
BX647140 human uterus endothel primary cell culture .h 1 to 4436 1 to 4437 exact tiling clone, available from DKFZ, AAA   4437/4437
(100 %)
8 diff
(99.9 %id)
AI872604 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .h 4276 to 4438 163 to 1       163/174
(93 %)
0 diff
(100 %id)
CA429424 Cell Line, Chondrosarcoma .i 1 to 688 706 to 19 F22X F44L I45X tiling clone, AAA   688/688
(100 %)
1 diff
(99.9 %id)
BQ775634 Bone, Human Chondrosarcoma Cell Line .i 175 to 688 532 to 19   AAA   514/514
(100 %)
0 diff
(100 %id)
CN404511 embryonic stem cells, cell lines H1, H7, andH9 .j 1 to 440 1 to 440   tiling clone,   440/440
(100 %)
1 diff
(99.8 %id)
DB084848 testis .j 29 to 578 2 to 551 exact tiling clone, capped   550/550
(100 %)
1 diff
(99.9 %id)
CN404524 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 1 to 510 1 to 512   tiling clone,   512/518
(98 %)
3 diff
(99.5 %id)
DB066656 testis .k 289 to 838 2 to 551 H26X tiling clone, capped   550/550
(100 %)
0 diff
(100 %id)
BP279319   .l 1 to 584 1 to 584 exact tiling clone,   584/584
(100 %)
0 diff
(100 %id)
AA225024   .m 1 to 347 34 to 383   tiling clone,   350/383
(91 %)
6 diff
(98.5 %id)
AW102917 ovary, tumor, 5 pooled (see description) .m 58 to 517 460 to 1       460/460
(100 %)
4 diff
(99.2 %id)
AI246663 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m 102 to 508 407 to 1       407/407
(100 %)
1 diff
(99.8 %id)
DA097763 cerebellum .m 211 to 675 2 to 468 L26S D27W Y28I K29I G30K ... tiling clone, capped   467/467
(100 %)
1 diff
(99.8 %id)
DA655095   .n 1 to 568 2 to 569 exact tiling clone, capped   568/568
(100 %)
1 diff
(99.9 %id)
BG680574 skin, squamous cell carcinoma .n 365 to 1168 1 to 805   tiling clone,   805/805
(100 %)
1 diff
(99.9 %id)
BI858118 breast, mammary adenocarcinoma, cell line .n 528 to 1162 1 to 635   tiling clone,   635/635
(100 %)
0 diff
(100 %id)
DB238577 trachea .o-u 1 to 602 2 to 604 exact tiling clone, capped   603/605
(99 %)
2 diff
(99.7 %id)
AA226631   .o-u 117 to 319 204 to 1       204/204
(100 %)
3 diff
(98.6 %id)
BF691675 melanotic melanoma, high MDR, skin .p 1 to 539 5 to 543 exact available from MGC,   543/543
(100 %)
4 diff
(99.3 %id)
BC007117 Skin, melanotic melanoma, high MDR. .p 1 to 552 4 to 555 exact tiling clone, available from MGC, AAA   555/555
(100 %)
2 diff
(99.7 %id)
BI037778 nervous_tumor Gene DCBLD2, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o-u, .p, .q-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI